VYNE Therapeutics Inc. (VYNE)
NASDAQ: VYNE · Real-Time Price · USD
2.861
+0.041 (1.45%)
Nov 21, 2024, 2:32 PM EST - Market open

VYNE Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Nov '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Market Capitalization
4233955265-
Upgrade
Market Cap Growth
109.26%273.57%-84.05%-79.42%--
Upgrade
Enterprise Value
-2817-273224-
Upgrade
Last Close Price
2.822.332.7018.36113.76-
Upgrade
PS Ratio
227.4676.7018.2558.6312.64-
Upgrade
PB Ratio
0.650.370.281.127.07-
Upgrade
P/TBV Ratio
0.440.370.281.127.07-
Upgrade
EV/Sales Ratio
-40.27-3.5810.69-
Upgrade
Debt / Equity Ratio
0.000.00-0.010.931.96
Upgrade
Asset Turnover
0.010.010.010.010.240.00
Upgrade
Inventory Turnover
----0.32-
Upgrade
Quick Ratio
5.5412.373.842.713.422.46
Upgrade
Current Ratio
5.8112.734.103.434.012.61
Upgrade
Return on Equity (ROE)
-90.47%-46.40%-84.81%-102.66%-928.19%-173.43%
Upgrade
Return on Assets (ROA)
-49.36%-26.42%-39.77%-30.25%-81.10%-64.82%
Upgrade
Return on Capital (ROIC)
-62.69%-30.39%-53.32%-40.11%-114.09%-83.09%
Upgrade
Earnings Yield
-80.66%-87.49%-266.62%-134.33%-96.35%-
Upgrade
FCF Yield
-71.12%-77.92%-335.43%-103.26%-51.72%-
Upgrade
Buyback Yield / Dilution
-1119.93%-222.44%-11.44%-58.75%-282.06%-31.22%
Upgrade
Total Shareholder Return
-1119.93%-222.44%-11.44%-58.75%-282.06%-31.22%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.